Clinical trial
Health Economics Evaluation of Catheter Ablation Versus Drug Therapy in Atrial Fibrillation (AF) in China
NCT01878981 is registered in ClinicalTrials.gov with Johnson & Johnson Medical, China as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Health Economics Evaluation of Catheter Ablation Versus Drug Therapy in Atrial Fibrillation (AF) in China
- Lead sponsor
- Johnson & Johnson Medical, China
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 30, 2011
- Completion date
- November 23, 2013
- Enrollment
- 450 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.